Iovance Biotherapeutics, Inc. (IOVA) operating margin

Operating margin · fiscal 2025
-151.1%

Iovance Biotherapeutics, Inc. (IOVA) had an operating margin of -151.1% in fiscal 2025 (the year ended December 31, 2025). That is 89.8 percentage points higher than the -240.9% of fiscal 2024. Figures as of 18 Nov 2026, 10:45 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Operating margin, fiscal 2025
-151.1%
Change on fiscal 2024
+89.8 pts
Highest on record
-151.1%fiscal 2025
Lowest on record
-38735.0%fiscal 2023
Fiscal years on record
32023–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Iovance Biotherapeutics, Inc. operating margin, in more detail

Across the 3 fiscal years on record (2023–2025), the highest was -151.1% in fiscal 2025 and the lowest -38735.0% in fiscal 2023.

Gross margin was 34.3% in fiscal 2025. Net margin was -148.4% in fiscal 2025.

History · 3 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Gross margin
  • Net margin

Iovance Biotherapeutics, Inc. operating margin, year by year

Iovance Biotherapeutics, Inc. (IOVA) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedGross marginNet margin
2025-151.1% 89.8 pts up34.3%-148.4%
2024-240.9% 38494.1 pts up43.2%-226.8%
2023-38735.0%—13.1%-37345.4%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

More on IOVA

Iovance Biotherapeutics, Inc., figure by figure

Iovance Biotherapeutics, Inc. (IOVA) overview: price, valuation and scorecard

Iovance Biotherapeutics, Inc. operating margin: questions and answers

What is Iovance Biotherapeutics, Inc.'s operating margin?

Iovance Biotherapeutics, Inc. (IOVA) had an operating margin of -151.1% in fiscal 2025 (the year ended December 31, 2025). That is 89.8 percentage points higher than the -240.9% of fiscal 2024.

What are the highest and lowest operating margin figures on record for Iovance Biotherapeutics, Inc.?

Across the 3 fiscal years on record (2023–2025), the highest was -151.1% in fiscal 2025 and the lowest -38735.0% in fiscal 2023.

What are Iovance Biotherapeutics, Inc.'s gross and net margins?

Gross margin was 34.3% in fiscal 2025. Net margin was -148.4% in fiscal 2025.

How is Iovance Biotherapeutics, Inc.'s operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income. For Iovance Biotherapeutics, Inc. it is on record here for 3 fiscal years, 2023 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Iovance Biotherapeutics, Inc. (IOVA) operating margin”, data as of 18 November 2026. https://funkfolio.com/stock/IOVA/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.